piroxicam

piroxicam (English)

3 October 2016

C₁₅H₁₃N₃O₄S

1 reference

piroxicam (English)

19 November 2016

CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3

1 reference

piroxicam (English)

19 November 2016

CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)/C(=N/C3=CC=CC=N3)/O

1 reference

Piroxicam (English)

19 November 2016

20 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=M01AC01

20 milligram

route of administration

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=M01AC01

20 milligram

route of administration

rectal route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=M01AC01

1 reference

14 February 2018

World Health Organisation international non-proprietary name

piroxicam (English)

1 reference

piroxicam (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

ankylosing spondylitis

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

Food and Drug Administration

13 December 2016

5 April 1982

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/13T4O6VMAM

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018147s044lbl.pdf

osteoarthritis

start time

5 April 1982

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/13T4O6VMAM

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018147s044lbl.pdf

significant drug interaction

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

bone marrow failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

gastrointestinal toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

leukopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mouth ulcer

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

cyclooxygenase inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D010894

non-steroidal anti-inflammatory drug

15 March 2018

1 reference

InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)

Medical Subject Headings

15 March 2018

2935.90.23

0 references

0 references

0 references

0 references

Piroxicam

0 references

Identifiers

InChI

1 reference

piroxicam (English)

19 November 2016

2 references

piroxicam (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

36322-90-4

2 references

piroxicam (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=36322-90-4

8 April 2021

1 reference

Piroxicam (English)

19 November 2016

2 references

piroxicam (English)

19 November 2016

Reaxys registry number

627692

1 reference

piroxicam (English)

3 October 2016

mapping relation type

2 references

PIROXICAM (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)

1 reference

PIROXICAM (English)

19 November 2016

2 references

inferred from InChIKey

splash10-014j-0591000000-7d11d429795ac27fa093

1 reference

MassBank accession ID

MSBNK-Keio_Univ-KO003803

0 references

MSBNK-Keio_Univ-KO003804

0 references

MSBNK-Keio_Univ-KO003805

0 references

MSBNK-Keio_Univ-KO003806

0 references

MSBNK-Keio_Univ-KO003807

0 references

MSBNK-Keio_Univ-KO009199

0 references

MSBNK-Keio_Univ-KO009200

0 references

MSBNK-Keio_Univ-KO001666

0 references

MSBNK-Keio_Univ-KO001667

0 references

MSBNK-Keio_Univ-KO001668

0 references

MSBNK-Keio_Univ-KO001669

0 references

MSBNK-Keio_Univ-KO001670

0 references

MSBNK-Waters-WA002537

0 references

MSBNK-Waters-WA002538

0 references

MSBNK-Waters-WA002539

0 references

MSBNK-Waters-WA002540

0 references

MSBNK-Waters-WA002541

0 references

MSBNK-Waters-WA002542

0 references

SPLASH

0 references

splash10-000t-0910000000-42d97ebe5da8190aa202

0 references

splash10-001m-2900000000-32c34cd63ced296fee89

0 references

splash10-00kf-5900000000-1d4473d813b920140b81

0 references

splash10-00lr-0009000000-9e65aa6e4b407ea80734

0 references

splash10-000f-3984000000-e855ded4bfe08c600884

0 references

splash10-007c-3900000000-fb37337024398fe8044d

0 references

splash10-006t-9600000000-db1bff24de3a9b89b68d

0 references

splash10-00r2-9200000000-22caea8b3219419be51f

0 references

splash10-01vk-6900000000-a75ce07d3bc58c9e773b

0 references

splash10-007a-1900000000-84047d0b4ba1f7510801

0 references

splash10-001i-5829000000-bfa87ed6f54b64fe3942

0 references

splash10-1000-1698000000-9bfc929b8cee2ec1d841

0 references

DSSTox substance ID

DTXSID5021170

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

252-974-3

1 reference

piroxicam (English)

ECHA Substance Infocard ID

19 November 2016

100.048.144

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Piroxicam (English)

CAS no.: 36322-90-4 (English)

1 reference

Piroxicam (English)

17 November 2015

1 reference

Piroxicam (English)

17 November 2015

1 reference

Guide to Pharmacology Ligand ID

Piroxicam (English)

publication date

17 November 2015

7273

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7273

piroxicam (English)

19 November 2016

Piroxicam

0 references

0 references

0 references

0 references

1 reference

piroxicam (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014694

2 references

based on heuristic

inferred from InChIKey

2 references

piroxicam (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

piroxicam (English)

19 November 2016

0 references

1 reference

1 reference

piroxicam (English)

3 October 2016

1 reference

Immune Epitope Database and Analysis Resource

piroxicam (English)

3 October 2016

1 reference

1 March 2022

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

piroxicam

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0132182

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Store medisinske leksikon ID

piroxicam

mapping relation type

exact match

subject named as

piroxicam

1 reference

Great Norwegian Encyclopedia

4 June 2020

1 reference

inferred by common MeSH mappings on source and on Wikidata

piroxicam (English)

19 November 2016

1 reference

25 May 2023

0 references

WordNet 3.1 Synset ID

03954317-n

1 reference